Uncategorized

Alizé Pharma 3

Alizé Pharma 3 moves forward with building a transatlantic biopharmaceutical company focused on rare endocrine and metabolic diseases

ORPHELIA Pharma has been awarded a €1m loan from BPIFrance

Interleukin-17 patent granted in Europe

JHAM2: Jumelage Handicap Aide Madagascar

The JHAM 2 project aims to implement a collective educational programme in 2017 following an observation phase.
A container has been sent in june 2017